help button home button Am J Pathol Epitomics Buy 2 Antibodies Get 1 Free Special Offer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shiao, Y. H.
Right arrow Articles by Scheer, W. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shiao, Y. H.
Right arrow Articles by Scheer, W. D.

American Journal of Pathology, Vol 144, 511-517, Copyright © 1994 by American Society for Investigative Pathology


REGULAR ARTICLES

p53 alteration in gastric precancerous lesions

YH Shiao, M Rugge, P Correa, HP Lehmann and WD Scheer
Department of Pathology, Louisiana State University Medical Center, New Orleans 70112.

It has been postulated that chronic atrophic gastritis, intestinal metaplasia, and dysplasia are precancerous stages of stomach tumorigenesis. We investigated the timing of p53 alterations in these events of gastric tumorigenesis. Each of 12 cases of archived tissue containing precancerous and cancerous lesions were selected for the detection of p53 alterations. Accumulation of p53 protein was detected by immunohistochemistry. Exons 5 to 8 of p53 gene were examined for mutations by polymerase chain reaction-single strand conformation polymorphism and DNA sequencing. p53 immunoreactivity was detected in 60% of the dysplasia cases and in 60% of the cases with carcinomas. p53 gene alterations were found in 37.5% of the metaplasia cases, 58.3% of the dysplasia cases, and 66.7% of the cases with carcinomas. In 71% of the cases, mutations were shown as G:C-->A:T transition. We conclude that mutation of the p53 gene is an early event in stomach tumorigenesis.


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Taguchi, N. Ohmiya, K. Shirai, N. Mabuchi, A. Itoh, Y. Hirooka, Y. Niwa, and H. Goto
Interleukin-8 Promoter Polymorphism Increases the Risk of Atrophic Gastritis and Gastric Cancer in Japan
Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2487 - 2493.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
W.-c. You, J.-Y. Hong, L. Zhang, K.-f. Pan, D. Pee, J.-y. Li, J.-l. Ma, N. Rothman, N. Caporaso, J. F. Fraumeni Jr., et al.
Genetic Polymorphisms of CYP2E1, GSTT1, GSTP1, GSTM1, ALDH2, and ODC and the Risk of Advanced Precancerous Gastric Lesions in a Chinese Population
Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 451 - 458.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. I. Meireles, E. B. Cristo, A. F. Carvalho, R. Hirata Jr., A. Pelosof, L. I. Gomes, W. K. Martins, M. D. Begnami, C. Zitron, A. L. Montagnini, et al.
Molecular Classifiers for Gastric Cancer and Nonmalignant Diseases of the Gastric Mucosa
Cancer Res., February 15, 2004; 64(4): 1255 - 1265.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. Akiyama, C. Maesawa, S. Ogasawara, M. Terashima, and T. Masuda
Cell-Type-Specific Repression of the Maspin Gene Is Disrupted Frequently by Demethylation at the Promoter Region in Gastric Intestinal Metaplasia and Cancer Cells
Am. J. Pathol., November 1, 2003; 163(5): 1911 - 1919.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. G. Fox, B. J. Sheppard, C. A. Dangler, M. T. Whary, M. Ihrig, and T. C. Wang
Germ-Line p53-targeted Disruption Inhibits Helicobacter-induced Premalignant Lesions and Invasive Gastric Carcinoma through Down-Regulation of Th1 Proinflammatory Responses
Cancer Res., February 1, 2002; 62(3): 696 - 702.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
M Rugge, V Russo, G Busatto, R M Genta, F Di Mario, F Farinati, and D Y Graham
The phenotype of gastric mucosa coexisting with Barrett's oesophagus
J. Clin. Pathol., June 1, 2001; 54(6): 456 - 460.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
K Takada
Epstein-Barr virus and gastric carcinoma
Mol. Pathol., October 1, 2000; 53(5): 255 - 261.
[Abstract] [Full Text]


Home page
Mol. Pathol.Home page
M Rugge, Y-H Shiao, G Busatto, M Cassaro, C Strobbe, V M Russo, G Leo, A R Parenti, A Scapinello, P Arslan, et al.
The p53 gene in patients under the age of 40 with gastric cancer: mutation rates are low but are associated with a cardiac location
Mol. Pathol., August 1, 2000; 53(4): 207 - 210.
[Abstract] [Full Text]


Home page
GutHome page
A Zullo, A Romiti, V Rinaldi, A Vecchione, S Tomao, F Aiuti, L Frati, and G Luzi
Gastric pathology in patients with common variable immunodeficiency
Gut, July 1, 1999; 45(1): 77 - 81.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Nishikawa, S. Imai, T. Oda, T. Kojima, K. Okita, and K. Takada
Epstein-Barr Virus Promotes Epithelial Cell Growth in the Absence of EBNA2 and LMP1 Expression
J. Virol., February 1, 1999; 73(2): 1286 - 1292.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American Society for Investigative Pathology.